Catheter-Related Bloodstream Infection Global Market Report 2024

Description

Catheter-related bloodstream infection (CRBSI) is a serious healthcare-associated infection caused by bacteria or fungi entering the bloodstream through a catheter-a tube used to administer medications or nutrients directly into a vein. This condition can lead to sepsis and other severe complications, emphasizing the critical need for prompt diagnosis and treatment.

The primary treatments for CRBSI include antibiotic lock therapy and antimicrobial agents. Antibiotic lock therapy involves infusing a concentrated antibiotic solution into the catheter lumen, where it remains for an extended period to prevent or eliminate catheter-related infections locally, without systemic administration. This approach is frequently employed in patients with central venous catheters to manage and prevent CRBSI. Common sources of infection and causative agents include Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumoniae), Candida species, Pseudomonas aeruginosa, among others. These treatments are available through hospital pharmacies, retail pharmacies, and online pharmacies.

The catheter-related bloodstream infection research report is one of a series of new reports from The Business Research Company that provides catheter-related bloodstream infection market statistics, including the catheter-related bloodstream infection industry's global market size, regional shares, competitors with a catheter-related bloodstream infection market share, detailed catheter-related bloodstream infection market segments, market trends and opportunities, and any further data you may need to thrive in the catheter-related bloodstream infection industry. This catheter-related bloodstream infection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The catheter-related bloodstream infection market size has grown strongly in recent years. It will grow from $1.44 billion in 2023 to $1.53 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth observed in the historic period can be attributed to several key factors, an increase in the incidence of chronic diseases, heightened awareness and education regarding healthcare, a rise in hospital-acquired infections, the growing elderly population, and the implementation of enhanced infection control programs in hospitals and healthcare settings.

The catheter-related bloodstream infection market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. In the forecast period, growth can be attributed to several factors, the increasing prevalence of healthcare-associated infections (HAIs), heightened awareness and training on infection control practices, expansion of healthcare infrastructure, a growing geriatric population, and supportive government policies and initiatives. Major trends anticipated during this period include innovations in biomaterials, advancements in smart catheter technology, the development of more effective catheter lock solutions with advanced antimicrobial properties, innovations in catheter sterilization processes, and the introduction of automated flushing systems.

The increasing incidence of hospital-acquired infections is anticipated to drive growth in the market for catheter-related bloodstream infections in the future. Hospital-acquired infections (HAIs) are infections that patients contract while undergoing treatment for other conditions in healthcare settings, typically emerging 48 hours or more after admission. Factors contributing to the rise in hospital-acquired infections include antimicrobial resistance, inadequate infection control protocols, and patient vulnerability. Catheter-related bloodstream infections are particularly problematic within HAIs due to the invasive nature of catheters and their potential for microbial colonization, posing risks to patients with indwelling catheters. For example, the National Library of Medicine reported in January 2023 that the global healthcare-associated infection (HAI) rate was 0.14%, with an annual increase of 0.06%. Hence, the escalating prevalence of hospital-acquired infections is set to propel growth in the catheter-related bloodstream infection market.

Leading companies in the catheter-related bloodstream infection market are focusing on developing innovative solutions such as catheter lock therapies to enhance infection prevention and improve patient outcomes. A catheter lock solution involves instilling a liquid into a catheter to prevent infections and maintain catheter patency between uses. For instance, in November 2023, CorMedix Inc., a US-based biopharmaceutical firm specializing in therapeutic products, received FDA approval for DefenCath (taurolidine and heparin) catheter lock solution. This solution is tailored for adult patients with kidney failure undergoing chronic hemodialysis through central venous catheters (CVCs), combining heparin for anticoagulation with taurolidine's broad-spectrum antimicrobial properties to reduce catheter-related bloodstream infections (CRBSIs).

In April 2022, CEMMA Medical Company Limited, based in Taiwan, partnered with LipoCoat BV to develop a coated central venous catheter (CVC) aimed at sustainable infection control. This collaboration leverages CEMMA's expertise in catheter technology and LipoCoat's bio-inspired coating technology, aiming to deliver an advanced CVC solution to combat the global challenge of healthcare-associated infections. LipoCoat BV, headquartered in the Netherlands, specializes in bio-inspired coating technologies.

Major companies operating in the catheter-related bloodstream infection market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis AG, 3M Company, Eli Lilly and Company, Fresenius Medical Care AG & Co. KGaA, Becton Dickinson and Company, Viatris Inc., B. Braun Medical Inc., Aurobindo Pharma Limited, Lupin Ltd., Xellia Pharmaceuticals Ltd., SteriMax Inc., Geistlich Pharma AG, Bactiguard AB, Hetero Healthcare Ltd., TauroPharm GmbH, Advacare Pharma, Citus Pharmaceuticals Inc., CorMedix Inc., JoinHub Pharma LLP, IntegraDose Compounding Services LLC

North America was the largest region in the catheter-related bloodstream infection market in 2023. The regions covered in the catheter-related bloodstream infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the catheter-related bloodstream infection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The catheter-related bloodstream infection market consists of revenues earned by entities by providing services such as blood culture testing, catheter flushing and maintenance, aseptic catheter insertion, hand hygiene training, and compliance monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The catheter-related bloodstream infection market also includes sales of catheters, catheter insertion kits, catheter maintenance equipment, monitoring and diagnostic devices, and infection control equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Catheter-Related Bloodstream Infection Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on catheter-related bloodstream infection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for catheter-related bloodstream infection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The catheter-related bloodstream infection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment: Antibiotic Lock Therapy; Anti-Microbial Agents
2) By Source Of Infection Or Causative Agents: Staphylococcus Aureus; Acinetobacter Baumannii; Escherichia Coli (E. Coli); Klebsiella Pneumoniae (K. Pneumonia); Candida Species (Candida Sp.); Pseudomonas Aeruginosa (P. Aeruginosa); Other Source Of Infection Or Causative Agents
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Novartis AG; 3M Company; Eli Lilly and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r19085

1. Executive Summary

2. Catheter-Related Bloodstream Infection Market Characteristics

3. Catheter-Related Bloodstream Infection Market Trends And Strategies

4. Catheter-Related Bloodstream Infection Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Catheter-Related Bloodstream Infection Market Size and Growth

5.1. Global Catheter-Related Bloodstream Infection Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Catheter-Related Bloodstream Infection Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Catheter-Related Bloodstream Infection Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Catheter-Related Bloodstream Infection Market Segmentation

6.1. Global Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antibiotic Lock Therapy
Anti-Microbial Agents
6.2. Global Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Staphylococcus Aureus
Acinetobacter Baumannii
Escherichia Coli (E. Coli)
Klebsiella Pneumoniae (K. Pneumonia)
Candida Species (Candida Sp.)
Pseudomonas Aeruginosa (P. Aeruginosa)
Other Source Of Infection Or Causative Agents
6.3. Global Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

7. Catheter-Related Bloodstream Infection Market Regional And Country Analysis

7.1. Global Catheter-Related Bloodstream Infection Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Catheter-Related Bloodstream Infection Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Catheter-Related Bloodstream Infection Market

8.1. Asia-Pacific Catheter-Related Bloodstream Infection Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Catheter-Related Bloodstream Infection Market

9.1. China Catheter-Related Bloodstream Infection Market Overview
9.2. China Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Catheter-Related Bloodstream Infection Market

10.1. India Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Catheter-Related Bloodstream Infection Market

11.1. Japan Catheter-Related Bloodstream Infection Market Overview
11.2. Japan Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Catheter-Related Bloodstream Infection Market

12.1. Australia Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Catheter-Related Bloodstream Infection Market

13.1. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Catheter-Related Bloodstream Infection Market

14.1. South Korea Catheter-Related Bloodstream Infection Market Overview
14.2. South Korea Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Catheter-Related Bloodstream Infection Market

15.1. Western Europe Catheter-Related Bloodstream Infection Market Overview
15.2. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Catheter-Related Bloodstream Infection Market

16.1. UK Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Catheter-Related Bloodstream Infection Market

17.1. Germany Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Catheter-Related Bloodstream Infection Market

18.1. France Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Catheter-Related Bloodstream Infection Market

19.1. Italy Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Catheter-Related Bloodstream Infection Market

20.1. Spain Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Catheter-Related Bloodstream Infection Market

21.1. Eastern Europe Catheter-Related Bloodstream Infection Market Overview
21.2. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Catheter-Related Bloodstream Infection Market

22.1. Russia Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Catheter-Related Bloodstream Infection Market

23.1. North America Catheter-Related Bloodstream Infection Market Overview
23.2. North America Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Catheter-Related Bloodstream Infection Market

24.1. USA Catheter-Related Bloodstream Infection Market Overview
24.2. USA Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Catheter-Related Bloodstream Infection Market

25.1. Canada Catheter-Related Bloodstream Infection Market Overview
25.2. Canada Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Catheter-Related Bloodstream Infection Market

26.1. South America Catheter-Related Bloodstream Infection Market Overview
26.2. South America Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Catheter-Related Bloodstream Infection Market

27.1. Brazil Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Catheter-Related Bloodstream Infection Market

28.1. Middle East Catheter-Related Bloodstream Infection Market Overview
28.2. Middle East Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Catheter-Related Bloodstream Infection Market

29.1. Africa Catheter-Related Bloodstream Infection Market Overview
29.2. Africa Catheter-Related Bloodstream Infection Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Catheter-Related Bloodstream Infection Market, Segmentation By Source Of Infection Or Causative Agents, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Catheter-Related Bloodstream Infection Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Catheter-Related Bloodstream Infection Market Competitive Landscape And Company Profiles

30.1. Catheter-Related Bloodstream Infection Market Competitive Landscape
30.2. Catheter-Related Bloodstream Infection Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson Services Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Novartis AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. 3M Company
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Eli Lilly and Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Catheter-Related Bloodstream Infection Market Other Major And Innovative Companies

31.1. Fresenius Medical Care AG & Co. KGaA
31.2. Becton Dickinson and Company
31.3. Viatris Inc.
31.4. B. Braun Medical Inc.
31.5. Aurobindo Pharma Limited
31.6. Lupin Ltd.
31.7. Xellia Pharmaceuticals Ltd.
31.8. SteriMax Inc.
31.9. Geistlich Pharma AG
31.10. Bactiguard AB
31.11. Hetero Healthcare Ltd.
31.12. TauroPharm GmbH
31.13. Advacare Pharma
31.14. Citus Pharmaceuticals Inc.
31.15. CorMedix Inc.

32. Global Catheter-Related Bloodstream Infection Market Competitive Benchmarking

33. Global Catheter-Related Bloodstream Infection Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Catheter-Related Bloodstream Infection Market

35. Catheter-Related Bloodstream Infection Market Future Outlook and Potential Analysis

35.1 Catheter-Related Bloodstream Infection Market In 2028 - Countries Offering Most New Opportunities
35.2 Catheter-Related Bloodstream Infection Market In 2028 - Segments Offering Most New Opportunities
35.3 Catheter-Related Bloodstream Infection Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer